Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Home-based cardiac rehabilitation after heart valve procedures

Official title: Home-Based Cardiac Rehabilitation Using a Novel Mobile Health Exercise Regimen Following Transcatheter Heart Valve Interventions

Run by Vanderbilt University Medical Center · NCT06077201 · Data updated 2026-11-12

This study tests a home-based cardiac rehab program using a mobile app to see if it helps people who have had heart valve procedures improve their health without going to a rehab center.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment240 (estimated)
SponsorVanderbilt University Medical Center
Academic / other
Locations1 site (Nashville, Tennessee)
StatusRecruiting
StartedDecember 15, 2023
Main results expectedFebruary 1, 2027
Study endsApril 1, 2027
Registry record updatedSeptember 4, 2026
Trial IDNCT06077201 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients who have undergone a transcatheter heart valve intervention via transfemoral access and are not planning to participate in center-based cardiac rehabilitation.

Probably not a fit

Patients who have had their transcatheter heart valve intervention through a route other than transfemoral or those requiring a walker may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates a home-based cardiac rehabilitation (HBCR) program delivered through a custom mobile app for patients who have undergone transcatheter heart valve interventions. Participants who are not planning to attend center-based cardiac rehabilitation will be randomized into three groups: a control group, a hands-off HBCR group, and an interactive HBCR group. The intervention aims to improve health behaviors and includes traditional cardiac rehabilitation components, with participants receiving either a 12-week or 24-week intervention. The study seeks to address the barriers that prevent individuals from participating in conventional rehabilitation programs.

Why it matters

Potential benefit: If successful, this approach could significantly enhance recovery and health outcomes for patients with valvular heart disease by providing accessible rehabilitation options.

How similar studies have gone: Other studies have shown promise in home-based rehabilitation approaches, indicating potential for success with this novel intervention.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Treated with a transcatheter heart valve intervention (e.g., transcatheter aortic valve implantation \[in the native valve or valve-in-valve\], mitral transcatheter edge-to-edge repair, mitral valve-in-valve) of the aortic, mitral, or tricuspid valve done via transfemoral access

Exclusion Criteria:

* Unwilling or unable to provide informed consent
* Not adherent to wearing the ActiGraph activity tracker during the roll-in phase for a minimum of 4 (out of 7) compliant days (worn \>10 hours/day)
* Planned participation in center based cardiac rehabilitation (CBCR)
* Transcatheter heart valve intervention done via any route other than a transfemoral approach
* Stroke during or immediately after the transcatheter heart valve intervention prior to randomization
* Placement of a pacemaker within 6 weeks prior to the transcatheter heart valve intervention or after the transcatheter heart valve intervention and prior to randomization
* Those who require a walker or who cannot get out of a chair/bed on their own and walk independently (use of a cane is acceptable)
* Physical or neuropsychiatric limitations that would prevent proficient use of the study tools and successful completion of the physical and quality of life assessments (e.g. blindness, dementia)
* Planned surgery within 6 months after the heart valve intervention
* Planned discharge from hospital to hospice, assisted living, or inpatient rehabilitation facility (discharge to a senior facility permitted as long as they are considered Independent Living)
* Treating provider or site PI indicates that participation in the study would be unsafe
* Participation in any ongoing randomized trial that has not completed follow-up unless the sponsor of the other trial allows enrollment of the participant in this cardiac rehabilitation trial
* Unable to complete the baseline study visit prior to 6 weeks after the transcatheter heart valve intervention

Where it's running

  • Vanderbilt University Medical Center
    Nashville, Tennessee, United States
    Recruiting

Study contacts

  • Principal investigator: Brian R. Lindman, MD, MSc — Vanderbilt University Medical Center
  • Study coordinator: Anna Vatterott, MPH
  • Email: anna.vatterott@vumc.org
  • Phone: 615-936-5798

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.